The DOI matches its Crossref record.
Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial
Open accessAbstract
Background—: Long-term comparative data of first-generation drug-eluting stents are scarce. We investigated clinical and angiographic outcomes of sirolimus-eluting (SES) and paclitaxel-eluting stents (PES) at 5 years as part of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) LATE study. Methods and Results—: A total of 1012 patients were randomly assigned to SES or PES. Repeat angiography was completed in 444 of 1012 patients (43.8%) at 5 years. Major adverse cardiac events occurred in 19.7% of SES- and 21.4% of PES-treated patients (hazard ratio, 0.89; 95% confidence interval, 0.68 to 1.17; P =0.39) at 5 years. There were no differences between SES and PES in terms of cardiac death (5.8% versus 5.7%; P =0.35), myocardial infarction (6.6% versus 6.9%; P =0.51), and target lesion revascularization (13.1% versus 15.1%; P =0.29). Between 1 and 5 years, the annual rate of target lesion revascularization was 2.0% (95% confidence interval, 1.4% to 2.6%) for SES and 1.4% (95% confidence interval, 0.9% to 2.0%) for PES. Among patients undergoing paired angiography at 8 months and 5 years, delayed lumen loss amounted to 0.37±0.73 mm for SES and 0.29±0.59 mm for PES ( P =0.32). The overall rate of definite stent thrombosis was 4.6% for SES and 4.1% for PES ( P =0.74), and very late definite stent thrombosis occurred at an annual rate of 0.65% (95% confidence interval, 0.40% to 0.90%). Conclusions—: Long-term follow-up of first-generation drug-eluting stents shows no significant differences in clinical and angiographic outcomes between SES and PES. The continuous increase in late lumen loss in conjunction with the ongoing risk of very late stent thrombosis suggests that vascular healing remains incomplete up to 5 years after implantation of first-generation drug-eluting stents. Clinical Trial Registration—: http://www.clinicaltrials.gov . Unique identifier: NCT00297661.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
Bangalore, S., Kumar, S., Fusaro, M., Amoroso, N., Attubato, M. J., Feit, F., Bhatt, D. L., & Slater, J. (2012) · Circulation · doi:10.1161/circulationaha.112.097014 · Cited by 574
Abdel-Wahab, M., Richardt, G., Joachim Büttner, H., Toelg, R., Geist, V., Meinertz, T., Schofer, J., King, L., Neumann, F.-J., & Khattab, A. A. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.07.017 · Cited by 533
Stefanini, G. G., Byrne, R. A., Serruys, P. W., de Waha, A., Meier, B., Massberg, S., Juni, P., Schomig, A., Windecker, S., & Kastrati, A. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs086 · Cited by 384
Self-citation
Metadata
- Authors
- Räber, L., Wohlwend, L., Wigger, M., Togni, M., Wandel, S., Wenaweser, P., Cook, S., Moschovitis, A., Vogel, R., Kalesan, B., Seiler, C., Eberli, F., Lüscher, T. F., Meier, B., Jüni, P., & Windecker, S.
- Venue
- Circulation
- Published
- 2011-06-21
- Volume
- 123
- Issue
- 24
- Pages
- 2819-2828
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1976886356
- Cited by
- 186
- References
- 0
- FWCI
- 29.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial. https://app.cochat.ai/papers/10.1161/circulationaha.110.004762
- The paper
- Räber, L., Wohlwend, L., Wigger, M., Togni, M., Wandel, S., Wenaweser, P., Cook, S., Moschovitis, A., Vogel, R., Kalesan, B., Seiler, C., Eberli, F., Lüscher, T. F., Meier, B., Jüni, P., & Windecker, S. (2011). Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial. Circulation. https://doi.org/10.1161/circulationaha.110.004762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.